As an expert in the field of ophthalmology, I am well-versed in the various conditions that can affect the human eye. One such condition is bull's eye vision, which is a term often used to describe a specific type of retinal damage known as chloroquine retinopathy. This condition is a serious concern for patients taking certain medications and is characterized by its unique pattern of retinal degeneration.

Chloroquine retinopathy, also referred to as Bull's eye maculopathy, is a type of retinal damage that results from the use of medications like chloroquine or hydroxychloroquine. These drugs are antimalarial agents that have also found use in the treatment of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus (SLE). The term "bull's eye" comes from the appearance of the retina when affected by this condition, which resembles the concentric circles of a target.

The retina is the light-sensitive tissue at the back of the eye that sends visual messages through the optic nerve to the brain. When the retina is damaged, as in the case of chloroquine retinopathy, it can lead to a decrease in vision quality and, in severe cases, blindness.

The damage caused by chloroquine or hydroxychloroquine is due to their accumulation in the pigmented cells of the retina, known as the retinal pigment epithelium (RPE). Over time, this accumulation can lead to cellular toxicity and death, which manifests as a characteristic ring-like pattern on the macula, the central part of the retina responsible for sharp, central vision.

The symptoms of chloroquine retinopathy can be subtle at first and may include:


1. Blurred vision: This is often the first noticeable symptom as the macula begins to be affected.

2. Difficulty with color vision: Patients may notice that colors appear less vibrant or that they have difficulty distinguishing between certain colors.

3. Loss of central vision: Over time, the central vision can be significantly impaired, making tasks like reading and recognizing faces challenging.

4. Scotomas: These are areas of reduced or lost vision that can occur in the central or peripheral visual field.

Diagnosis of chloroquine retinopathy typically involves a comprehensive eye exam, including:


1. Visual acuity testing: To measure how clearly one can see at various distances.

2. Dilated eye exam: This allows the ophthalmologist to examine the retina and look for signs of damage.

3. Fundus photography: Taking photographs of the retina can help document the condition and monitor its progression.

4. OCT (Optical Coherence Tomography): This advanced imaging technique provides a detailed cross-sectional view of the retina.

Treatment for chloroquine retinopathy primarily involves discontinuing the use of the offending drug. In some cases, the damage may be irreversible, but stopping the medication can prevent further harm. There is currently no cure for the condition, but supportive care can help manage symptoms and maintain the best possible vision.

Prevention is key, and it includes regular eye exams for patients on long-term chloroquine or hydroxychloroquine therapy. Monitoring for early signs of retinopathy can allow for timely intervention and potentially prevent severe vision loss.

In conclusion, bull's eye vision or chloroquine retinopathy is a serious ocular condition that requires careful monitoring and management. It serves as a reminder of the importance of the balance between the benefits and risks of medication use, particularly for long-term treatments.

read more >>

Chloroquine retinopathy. Chloroquine retinopathy, also known as Bull's eye maculopathy, is a retinopathy (damage of the retina) caused by the drugs chloroquine or hydroxychloroquine, which are sometimes used in the treatment of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus.read more >>